Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes

被引：0
|
作者：
Özlem Seçilmiş Kerimoğlu
Cihangir Mutlu Ercan
Uğur Keskin
Cem Korkmaz
Namık Kemal Duru
Ali Ergün
机构：
[1] Selçuk University Medicine Faculty,Department of Obstetrics and Gynecology
[2] Gülhane Military Medicine Faculty,Department of Obstetrics and Gynecology
[3] Gülhane Military Medicine Faculty,Department of Histology and Embryology
来源：
Archives of Gynecology and Obstetrics | 2013年 / 288卷
关键词：
Antagonist; Cetrorelix; In vitro fertilization; LH surge;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 695
页数：4
相关论文
共 50 条
  • [41] Combined Administration of Gonadotropin-releasing Hormone Agonist with Human Chorionic Gonadotropin for Finall Oocyte Maturation in GnRH Antagonist Cycles for in Vitro Fertilization
    Kim, Chung-Hoon
    Ahn, Jun-Woo
    You, Rae-Mi
    Kim, Sung-Hoon
    Chae, Hee-Dong
    Kang, Byung-Moon
    JOURNAL OF REPRODUCTIVE MEDICINE, 2014, 59 (1-2) : 63 - 68
  • [42] Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders
    Dragisic, KG
    Davis, OK
    Fasouliotis, SJ
    Rosenwaks, Z
    FERTILITY AND STERILITY, 2005, 84 (04) : 1023 - 1026
  • [43] Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome
    Lorusso, F
    Depalo, R
    Selvaggi, L
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 18 (02) : 69 - 73
  • [44] Inhibition of in vivo and in vitro fertilization in rodents by gonadotropin-releasing hormone antagonists
    Morales, P
    Pasten, C
    Pizarro, E
    BIOLOGY OF REPRODUCTION, 2002, 67 (04) : 1360 - 1365
  • [45] A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
    Jumpei Asakawa
    Taro Iguchi
    Satoshi Tamada
    Sayaka Yasuda
    Noriko Ninomiya
    Minoru Kato
    Takeshi Yamasaki
    Tetusji Ohmachi
    Tatsuya Nakatani
    Basic and Clinical Andrology, 28
  • [46] A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
    Asakawa, Jumpei
    Iguchi, Taro
    Tamada, Satoshi
    Yasuda, Sayaka
    Ninomiya, Noriko
    Kato, Minoru
    Yamasaki, Takeshi
    Ohmachi, Tetusji
    Nakatani, Tatsuya
    BASIC AND CLINICAL ANDROLOGY, 2018, 28
  • [47] Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in vitro fertilization-embryo transfer patients
    Escudero, E
    Bosch, E
    Crespo, J
    Simón, C
    Remohí, J
    Pellicer, A
    FERTILITY AND STERILITY, 2004, 81 (03) : 562 - 566
  • [48] Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in vitro fertilization
    Kaye, Leah
    Griffin, Daniel
    Thorne, Jeffrey
    Neuber, Evelyn
    Nulsen, John
    Benadiva, Claudio
    Engmann, Lawrence
    FERTILITY AND STERILITY, 2019, 112 (03) : 534 - 544
  • [49] Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose
    Ponzano, Adalisa
    Colangelo, Enrica Concetta
    Di Biase, Lucia
    Romani, Federica
    Tiboni, Gian Mario
    GYNECOLOGICAL ENDOCRINOLOGY, 2017, 33 (03) : 208 - 211
  • [50] Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?
    Fauser, BCJM
    Devroey, P
    FERTILITY AND STERILITY, 2005, 83 (06) : 1607 - 1611
12345